Instrument Inactif

Communiqués Cytomedix, Inc. OTC Bulletin Board

Actions

CMXI

US23283B2043

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

15/05	Nuo Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
19/04	Nuo Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	26/06/23	AQ
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	22/06/23	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	17/04/23	AQ
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	05/12/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	04/11/22	AQ
NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)	30/09/22	AQ
Nuo Therapeutics Provides Corporate and Business Update	30/08/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	30/08/22	AQ
Nuo Therapeutics : Amendment to Quarterly Report - Form 10-Q/A	10/08/22	PU
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	10/08/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	08/08/22	AQ
NUO THERAPEUTICS, INC. : Other Events (form 8-K)	28/06/22	AQ
Nuo Therapeutics : Statement of Changes in Beneficial Ownership (Form 4)	16/06/22	PU
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/05/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/05/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/04/22	AQ
Nuo Therapeutics Responds to Mini-Tender Offer	04/02/22	GL
Alternative Liquidity Index Announces Offer to Purchase Shares in Nuo Therapeutics, Inc.	21/01/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	04/01/22	AQ
NUO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21/04/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cytomedix, Inc. OTC Bulletin Board

Actions

CMXI

US23283B2043

Communiqués

Filtres